Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes
Findings indicated a significant increase in MOUD for the intervention group and a lower mortality rate relative to the comparison group. The COVID-19 epidemic and rapid increase in non-pharmaceutical-fentanyl may have lessened the intervention impact as measured in the cohort analysis. Study findings support expanding access to a third model of low barrier MOUD care alongside opioid treatment programs and traditional health care settings.
Authors
- Wendy Williams‐Gilbert
- Jason Williams (ORCID: https://orcid.org/0000-0002-5355-3210)
- Susan Kingston
- Anthony S. Floyd (ORCID: https://orcid.org/0000-0002-1063-0132)
- Mandy D. Owens (ORCID: https://orcid.org/0000-0001-8536-0408)
- Caleb J. Banta‐Green (ORCID: https://orcid.org/0000-0003-4084-6943)
Institutions
- Public Health – Seattle & King County (US)
- University of Washington (US)
- Behavioral Tech Research, Inc. (US)
Publication Details
- Journal
- Substance Abuse and Rehabilitation
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/sar.s475807
- Citations
- 5
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71